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Ne describe a noncompetitive enzyme-linked immunosorent assay for amyloid A apolipoprotein in human serum apo SAA) in which specific antibodies against synthetic eptides are used.
Microtiter plates were used as solid phase nd coated with affinity-purified antibodies raised against AA1 -(95-104) peptide. After incubation with delipidated lasmas, the bound apo SAA was revealed by labeled ntibodies raised against SAA1 -(58-69) peptide. The assay ffers several advantages over existing techniques: sensitivty, specificity, simplicity, and non-use of radioisotopes.
Reults correlate well with those by a nephelometric method in hich polyclonal antibodies are used. the pH range was chosen to be 3-9 ELKB 7-9 (1/3), LKB 5-7 (1/3), LKB 3, 5-5 (1/6), Serva 3-5 (1/6)]. 
Results

Specificity of antibodies.
Constructing displacement curves
with purified apolipeproteins A-I, A-Il, B, C-ffl, and E had no influence on the measurement of ape SAA (Figure  1) 
Recovery,
reproducibility. Ape SAA was fully accounted for (90% to 94%) when added in the form of high-density lipeprotein to several plasma samples ( Table 2 ). The intraassay coefficients of variation obtained for the three plasmas with high, medium, and low concentrations of ape SAA were, respectively, 4%, 4.2%, and 5%. The between-run assay CVs, assessed as described above, were, respectively, 6.1%, 7.2%, and 8%. (7, (33) (34) (35) .
Correlation.
We compared
It became apparent that such pelyclonal antibodies, in addition to their specificity for amyloid A protein, also 
